Temocillin efficacy against AmpC β-lactamase-producing Enterobacterales: a relevant alternative to cefepime?
Temocillin appears to be reliable for ABPE infections. Our data showed a high therapeutic success rate. Its high tolerability, narrow spectrum and ease of administration could make temocillin a relevant alternative to cefepime, the current standard for ABPE infection.
Authors
- Marin Lahouati (ORCID: https://orcid.org/0000-0003-0043-7336)
- Anissa Desmoulin (ORCID: https://orcid.org/0000-0001-7204-481X)
- F. Andry (ORCID: https://orcid.org/0000-0001-6343-5130)
- Xavier Brousse (ORCID: https://orcid.org/0000-0001-6345-9685)
- Philippe Lehours (ORCID: https://orcid.org/0000-0001-6077-1825)
- Paul Petitgas (ORCID: https://orcid.org/0000-0002-0517-6203)
- Anne‐Gaëlle Leroy (ORCID: https://orcid.org/0000-0003-2245-9632)
- Laurine Rignol
- Quentin Charroyer
Institutions
- Université de Bordeaux (FR)
- Inserm (FR)
- Centre Hospitalier Universitaire de Bordeaux (FR)
- Bordeaux Population Health (FR)
- Peuplements végétaux et bioagresseurs en milieu tropical (RE)
- BoRdeaux Institute of onCology (FR)
Publication Details
- Journal
- Journal of Antimicrobial Chemotherapy
- Published
- 2024-12-23
- DOI
- https://doi.org/10.1093/jac/dkae449
- Citations
- 2
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 0.34